Self-driven, dynamic real-world haptic assessment for optimal pain management in the community and clinic.

自我驱动、动态的现实世界触觉评估，以实现社区和诊所的最佳疼痛管理。

• 批准号: 10042734
• 金额: $ 5.71万
• 依托单位: NEUROTACT LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10042734
• 关键词: Self; driven; dynamic; real; world

Neurotact created the first-of-its kind novel haptic device that assesses pain holistically and offers a personalised record for each patient. It is the only pain assessment tool that is tangible (by employing touch). It is easy to use and puts the patient in the driving seat by using Neurotact's AI-driven data analytics and pain visualisation. It is designed to be intuitive and avoids the use of questionnaires, making it a quick and easy experience. Neurotact offers the ability to calibrate assessment for each user. Using a tactile hand-held manipulable device employing multidimensional sensor data and measures pain through time and allows users to visualise their pain as a pain signature. With an AI-powered platform. Neurotact provides a comprehensive pain score, treatment outcome and pain behaviour change predictions.Every day in every clinical facility in the world patients are asked to report on their pain (intensity, location, severity, duration, impact). Given how common this task is, it is surprising that pain assessment tools haven't meaningfully changed in the last fifty years, despite well-documented shortcomings. Current pain assessment requires patients to reduce and transform their experience into a verbal (using words such as severe, mild, moderate) or numerical representation (from 1-10). This simplification forces the complex quality of pain into an oversimplified 'mark' that sacrifices all of the rich information. This simplification is much hated by patients.Neurotact offers individuals the ability to visualise their own pain signature. Importantly, it can be used at home or on the move. It liberates pain assessment from the clinic and gives the power back to the individual who can assess pain as it is happening. Together patients and clinicians can tailor their treatment and monitor changes associated with treatment, putting the assessment back in control of the patient.Further, data can also be aggregated across patients to build phenotypes of patient pain experience related to specific contexts (e.g. cancer pain, pain after surgery, chronic pain). These patterns can provide clinicians with a better picture of common patient pathways of pain, allowing for smarter treatment tailoring.Neurotact is an investable British innovation that can provide a self-driven healthcare solution for people living with pain, trying to assess when and how pain becomes unmanageable.

Neurotact创造了第一种新型触觉设备，可以全面评估疼痛，并为每位患者提供个性化记录。它是唯一的疼痛评估工具，是有形的（通过采用触摸）。它易于使用，并通过使用Neurotact的人工智能驱动的数据分析和疼痛可视化将患者置于驾驶席上。它的设计是直观的，避免了使用问卷，使其成为一个快速和简单的经验。Neurotact提供了为每个用户校准评估的能力。使用触觉手持可操纵设备，采用多维传感器数据，测量随时间推移的疼痛，并允许用户将其疼痛可视化为疼痛特征。一个AI驱动的平台。Neurotact提供全面的疼痛评分、治疗结果和疼痛行为变化预测。世界各地的每一家临床机构每天都要求患者报告他们的疼痛（强度、位置、严重程度、持续时间、影响）。考虑到这项任务是多么普遍，令人惊讶的是，疼痛评估工具在过去的50年里没有发生有意义的变化，尽管有充分的证据证明存在缺陷。目前的疼痛评估要求患者减少并将他们的经历转化为口头（使用严重，轻度，中度等词语）或数字表示（从1-10）。这种简单化迫使痛苦的复杂性质变成一个过于简单的“标记”，牺牲了所有丰富的信息。这种简单化是病人非常讨厌的。Neurotact为个人提供了可视化自己疼痛信号的能力。重要的是，它可以在家里或移动中使用。它将疼痛评估从诊所中解放出来，并将权力交还给能够在疼痛发生时评估疼痛的个人。患者和临床医生可以一起定制他们的治疗并监测与治疗相关的变化，将评估重新置于患者的控制之下。此外，还可以汇总患者的数据，以构建与特定背景相关的患者疼痛体验表型（例如癌症疼痛，手术后疼痛，慢性疼痛）。这些模式可以为临床医生提供更好的患者疼痛途径的图片，允许更智能的治疗定制。Neurotact是一项可投资的英国创新，可以为患有疼痛的人提供自我驱动的医疗保健解决方案，试图评估疼痛何时以及如何变得无法控制。